Update on autoimmune hepatitis

Por Teufel, Andreas, Galle, Peter R, Kanzler, Stephan
Publicado em 2009

Genetics of hepatocellular carcinoma

Por Teufel, Andreas, Staib, Frank, Kanzler, Stephan, Weinmann, Arndt, Schulze-Bergkamen, Henning, Galle, Peter R
Publicado em 2007

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

Por Sprinzl, Martin F., Wytopil, Sonia M., Dahmen, Anja, Kanzler, Stephan, Galle, Peter R., Moehler, Markus
Publicado em 2008

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

Por Sprinzl, Martin F, Schimanski, Carl C, Moehler, Markus, Schadmand-Fischer, Simin, Galle, Peter R, Kanzler, Stephan
Publicado em 2006

Hepatocellular carcinoma in patients with autoimmune hepatitis

Por Teufel, Andreas, Weinmann, Arndt, Centner, Catherine, Piendl, Anja, Lohse, Ansgar W, Galle, Peter R, Kanzler, Stephan
Publicado em 2009

Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients

Por Teufel, Andreas, Wörns, Markus, Weinmann, Arndt, Centner, Catherine, Piendl, Anja, Lohse, Ansgar W, Galle, Peter R, Kanzler, Stephan
Publicado em 2006

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Por Mihaljevic, Andre, Büchler, Peter, Harder, Jan, Hofheinz, Ralf, Gregor, Michael, Kanzler, Stephan, Schmiegel, Wolff, Heinemann, Volker, Endlicher, Esther, Klöppel, Günter, Seufferlein, Thomas, Geissler, Michael
Publicado em 2009

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

Por Moehler, Markus, Sprinzl, Martin F, Abdelfattah, Murad, Schimanski, Carl C, Adami, Bernd, Godderz, Werner, Majer, Klaus, Flieger, Dimitri, Teufel, Andreas, Siebler, Juergen, Hoehler, Thomas, Galle, Peter R, Kanzler, Stephan
Publicado em 2009

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded pha...

Por Schimanski, Carl Christoph, Möhler, Markus, Schön, Michael, van Cutsem, Eric, Greil, Richard, Bechstein, Wolf Otto, Hegewisch-Becker, Susanna, von Wichert, Götz, Vöhringer, Matthias, Heike, Michael, Heinemann, Volker, Peeters, Marc, Kanzler, Stephan, Kasper, Stefan, Overkamp, Friedrich, Schröder, Jan, Seehofer, Daniel, Kullmann, Frank, Linz, Bernhard, Schmidtmann, Irene, Smith-Machnow, Victoria, Gockel, Ines, Lang, Hauke, Galle, Peter R
Publicado em 2012

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO...

Por Moehler, Markus, Gepfner-Tuma, Irina, Maderer, Annett, Thuss-Patience, Peter C., Ruessel, Joern, Hegewisch-Becker, Susanna, Wilke, Hansjochen, Al-Batran, Salah-Eddin, Rafiyan, Mohammad-Reza, Weißinger, Florian, Schmoll, Hans-Joachim, Kullmann, Frank, von Weikersthal, Ludwig Fischer, Siveke, Jens T., Weusmann, Jens, Kanzler, Stephan, Schimanski, Carl Christoph, Otte, Melanie, Schollenberger, Lukas, Koenig, Jochem, Galle, Peter R.
Publicado no BMC Cancer (2016)